Pages that link to "Q34102290"
Jump to navigation
Jump to search
The following pages link to Options and obstacles for designing a universal influenza vaccine (Q34102290):
Displaying 20 items.
- Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. (Q30384878) (← links)
- Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1. (Q30387699) (← links)
- Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice (Q35913758) (← links)
- A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose (Q36736786) (← links)
- Development of cross-protective influenza a vaccines based on cellular responses (Q38510148) (← links)
- A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza (Q38983251) (← links)
- Type II transmembrane serine proteases as potential target for anti-influenza drug discovery (Q40058871) (← links)
- Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice (Q41377165) (← links)
- Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants (Q41924161) (← links)
- Influenza vaccination in pediatric age. (Q43680457) (← links)
- Towards the Application of Human Defensins as Antivirals (Q47557198) (← links)
- Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza. (Q50533261) (← links)
- Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens. (Q52344693) (← links)
- Novel Platforms for the Development of a Universal Influenza Vaccine. (Q52599675) (← links)
- Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo (Q57093983) (← links)
- Investigating Different Mechanisms of Action in Combination Therapy for Influenza (Q58573517) (← links)
- Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union (Q61803450) (← links)
- Computational Approaches and Challenges to Developing Universal Influenza Vaccines (Q92376654) (← links)
- A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine (Q92660315) (← links)
- An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs (Q92997269) (← links)